According to FutureWise analysis, the market for Acute Respiratory Distress Syndrome is expected to grow at a CAGR of 10.30% over the forecast period of 2023-2031.
Acute Respiratory Distress Syndrome (ARDS) is a severe medical condition that affects the lungs. It is characterized by inflammation and fluid accumulation in the lungs' tiny air sacs (alveoli), leading to impaired oxygenation and ventilation. ARDS typically occurs as a response to an underlying injury or illness, such as pneumonia, sepsis, trauma, or inhalation of harmful substances. The development of ARDS involves a complex chain of events. When an injury or infection triggers an inflammatory response, immune cells release various substances, including inflammatory cytokines. These cytokines cause damage to the delicate lung tissue, leading to increased permeability of the alveolar-capillary membrane. As a result, fluid leaks from the capillaries into the alveoli, impairing the exchange of oxygen and carbon dioxide. The fluid accumulation in the lungs further compromises lung function and leads to severe respiratory distress. Patients with ARDS often experience rapid and shallow breathing, severe shortness of breath, low blood oxygen levels, and lung infiltrates visible on imaging tests.
Acute respiratory distress syndrome (ARDS) affects roughly one-third or (33%) of hospitalized patients, according to a study named "Acute respiratory distress syndrome in COVID-19: possible mechanisms and therapeutic management," published in the Springer in December 2021. Additionally, of the COVID-19 patients admitted to the intensive care unit, 75% (or nearly 3/4) have ARDS. The prognosis and fatality rate for ARDS patients with COVID-19 are not favorable. As a result, COVID-19 has significantly impacted the market for acute respiratory distress.
FutureWise Market Research has published a report that provides an insightful analysis of Acute Respiratory Distress Syndrome (ARDS) Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes the stature of key manufacturers operational in this industry.
According to the analysis conducted by FutureWise research analysts, Acute Respiratory Distress Syndrome (ARDS) Market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition to providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organization to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.